Empirical Asset Management »

United Therapeutics Corporation shares owned by Empirical Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Empirical Asset Management from 13F filings

Historical chart of Empirical Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Empirical Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Empirical Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $981k 2.3k 419.21

More positions owned by Empirical Asset Management

Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr U.s. Tech Etf (IYW)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Meta Platforms Cl A (META)
Home Depot (HD)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Uscf Etf Tr Summerhaven K1 (SDCI)
Spdr Gold Tr Gold Shs (GLD)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)

View all positions for Empirical Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation